In the CTRP database, we observed that bladder cancer with high LIG1 expression was resistant to drugs including SGX-523, compound 1B, NSC30930, SJ-172550, Fumonisin B1, TGX-221, CAY10576, Lovastatin, Selumetinib, CID-5951923 and others. Here, LIG1 is linked to urinary bladder cancer.